10 Years Of MedImmune: What Trademark Owners Learned
James E. Griffith
Michelle Bolos Ten years ago, the Supreme Court redefined the standards for declaratory judgment jurisdiction in patent cases, forcing practitioners to reimagine intellectual property enforcement strategies. In MedImmune LLC v. Genentech Inc., the Supreme Court held that a...
To view the full article, register now.